This Trading Plan (the "Trading Plan") is entered into on November 15, 2018 ("Seller's Adoption Date") between Medpace Investors LLC ("Seller") and UBS Financial Services Inc. ("UBSFS") for the purpose of selling, in accordance with Rule 10b5-1(c)(1)...Trading Plan • February 6th, 2019 • Troendle August J. • Services-commercial physical & biological research • New York
ContractTrading Plan • October 2nd, 2018 • Troendle August J. • Services-commercial physical & biological research • New York
VOTING AGREEMENTVoting Agreement • August 26th, 2016 • Troendle August J. • Services-commercial physical & biological research • Delaware
THIS VOTING AGREEMENT, dated as of August 10, 2016, is entered into by and between (i) Dr. August J. Troendle (“Dr. Troendle”) and (ii) the entities listed on Schedule 1 attached hereto (collectively, the “Cinven Stockholders” and, together with Dr. Troendle, the “Principal Stockholders”). Capitalized terms used herein without definition shall have the meanings set forth in Section 1.1.
Rule 10b5-l Trading PlanTroendle August J. • July 6th, 2022 • Services-commercial physical & biological research • New York
This Trading Plan (the “Trading Plan”) is entered into on 3/17/22 (“Purchaser’s Adoption Date”) between Medpace Investors LLC (“Purchaser”) and UBS Financial Services Inc. (“UBSFS”) for the purpose of purchasing shares of the common stock (“Stock”) of Medpace Holdings Inc (“Issuer”), MEDP (Ticker), listed in Exhibit A, in accordance with Rule 10b5-l(c)(1) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
Rule 10b5-l Trading PlanTrading Plan • September 22nd, 2023 • Troendle August J. • Services-commercial physical & biological research • New York
between Medpace Investors LLC (“Seller”) and UBS Financial Services Inc. (“UBSFS“) for the purpose of selling, in accordance with Rule 10b5-l (c)(1) of the Securities Exchange Act of 1934 as amended (the “Exchange Act”), shares of common stock of Medpace Holdings, Inc. (“Issuer”), MEDP (Ticker) listed on Exhibit A (“Stock”), which may include shares that the Seller has the right to acquire under outstanding stock options (“the Options”); shares that arc acquired by Seller pursuant to the Issuer’s employee stock purchase plan (the “ESPP Stock”); shares that are acquired upon vesting of outstanding restricted stock units/awards from Issuer (“RSUs/RSAs”); and shares that are acquired upon vesting of outstanding performance share awards from Issuer (“PSAs”).
JOINT FILING AGREEMENTJoint Filing Agreement • August 26th, 2016 • Troendle August J. • Services-commercial physical & biological research
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Form of Lock-up AgreementUp Agreement • August 26th, 2016 • Troendle August J. • Services-commercial physical & biological research • New York
Amendment to Rule 10b5-l Trading PlanTroendle August J. • September 13th, 2022 • Services-commercial physical & biological research
The Trading Plan dated 3/17/2022 and amended 5/3/2022 (the “Trading Plan”) entered into between Medpace Investors LLC (“Purchaser”) and UBSFS, acting as agent, for the purpose of establishing a trading plan that complies with Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is amended on August 15, 2022 as follows, with the consent of UBSFS:
